drugset / Trial / NCT00450515

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

NCT00450515 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as vinflunine and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving vinflunine together with capecitabine works in treating patients with previously treated metastatic breast cancer.

Timeline

Start
2007-03
Primary completion
2009-01
Completion
2009-01

Outcome

Outcome not reported

Stopped: “Study was dropped prior to opening.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — Oral
Subject Vinflunine Small molecule — Intravenous

Indications